Ownership history in Bayesian Capital Management, LP · 8 quarters on record
This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 25,500 | -12,400 | -32.7% | 0.12% | $577K | $22.63 |
| 2025 Q1 | ADDED | 37,900 | +6,700 | +21.5% | 0.14% | $829K | $21.87 |
| 2024 Q3 | ADDED | 31,200 | +13,925 | +80.6% | 0.11% | $900K | $28.84 |
| 2023 Q4 | ADDED | 17,275 | +8,151 | +89.3% | 0.11% | $1.0M | $59.86 |
| 2023 Q2 | REDUCED | 9,124 | -8,800 | -49.1% | 0.09% | $831K | $91.10 |
| 2023 Q1 | ADDED | 17,924 | +6,324 | +54.5% | 0.15% | $1.2M | $65.96 |
| 2022 Q2 | REDUCED | 11,600 | -2,400 | -17.1% | 0.10% | $525K | $45.22 |
| 2022 Q1 | INITIATED | 14,000 | — | — | 0.11% | $711K | $50.81 |
As of 2025 Q4 — sorted by position size